Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
UCB
Pharma
Results for UCB's Fintepla pave way for 3rd epileptic indication
UCB plans to file for regulatory approval of Fintepla to treat a third epileptic condition “as soon as possible,” the company said.
Kevin Dunleavy
Dec 8, 2025 11:19am
Rising Stars: How Katie Swicegood Fulp made the leap to pharma
Nov 5, 2025 6:00am
Fast-rising UCB scores FDA nod for rare disease drug Kygevvi
Nov 4, 2025 11:36am
J&J's Imaavy comes up short in rheumatoid arthritis study
Aug 29, 2025 10:56am
Argenx pursues Vyvgart nod in seronegative myasthenia gravis
Aug 25, 2025 11:38am
FDA's response letter salvo sheds light on drug refusal process
Jul 11, 2025 10:15am
